期刊文献+

生长抑素受体1~3亚型蛋白在胃癌中的表达及临床意义 被引量:2

Expressions of somatostatin receptor subtypes 1~3 in gastric carcinoma
下载PDF
导出
摘要 目的探讨生长抑素受体(somatostatin receptor,SSTR)1~3亚型蛋白在胃癌发生、发展中的作用及其相关性。方法对病理确诊的47例胃癌组织标本采用免疫组化二步法检测SSTR1~3亚型蛋白的表达。采用Fisher精确概率法分析临床相关因素与上述指标的相关性。结果SSTR1—3亚型蛋白的表达与患者的性别、肿瘤的部位、有无淋巴结转移及临床分期无统计学意义(P〉0.05);20例浸润型胃癌SSTR1阳性表达率为50.O%,26例溃疡型胃癌中SSTR1阳性表达率为80.77%,两组比较有显著性差异(P〈0.05);14例高/中分化SSTR2阳性率为71.43%,33例低分化SSTR2阳性率为30.30%,两组比较有显著性差异(P〈0.05);20例浸润型胃癌SSTR3阳性表达率为30.00%,26例溃疡型胃癌中SSTR3阳性表达率为69.23%,两组比较有显著性差异(P〈0.05);14例高/中分化SSTR3阳性率为78.57%,33例低分化SSTR3阳性率为42.42%,两组比较有显著性差异(P〈0.05)。结论SSTR1~3亚型可能与胃癌的发生、发展有关,并参与抑制胃癌细胞的增殖。 Objective To study the role of somatostatin receptor (SSTR) subtypes 1 - 3 in the process of genesis, development of gastric carcinoma and their relationship. Methods Two-step immunohistochemical staining was used to examine the expressions of SSTR1 -3 in 47 cases of gastric specimens, then the relationship between them and clinical pathology was analyzed by Fisher test. Results The expressions of SSTR1 - 3 were not related to gender, the location, lymph node metastasis and clinical stage (P 〉0.05) ; the expression rates of SSTR1 and SSTR3 in 20 cases of invaded gastric carcinoma (50. 00% , 30.00% ) were lower than that in 26 cases of ucler gastric carcinoma (80.77% , 69.23% )(P 〈 0.05); the expression rates of SSTR2 and SSTR3 in 14 cases of high/middle differentiation degree (71.43%, 78.57% ) were higher than that in 33 cases of low differentiation degree (31.25%, 42.42% ) ( P 〈 0.05 ). Conclusion SSTR1 - 3 may play an important role in the development and genesis of gastric carcinoma, and it inhibites the proliferation of gastric carcinoma.
出处 《胃肠病学和肝病学杂志》 CAS 2008年第10期826-828,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 胃癌 生长抑素 生长抑素受体 免疫组化 Gastric carcinoma Somatostatin Somatostatin receptor Immunohistochemistry
  • 相关文献

参考文献10

  • 1Kwekkeboom D J, Krenning EP. Somatostatin receptor imaging [ J]. Semin Nucl Med, 2002, 32(2):84-91.
  • 2Hofland LJ, Lamberts SW. Somatostatin receptor subtype expression in human tumors [J]. Ann Oneol, 2001, 12(Suppl 2): S31-36.
  • 3Grant MB, Caballero S. Somatostatin analogues as drug therapies for retinopathies [J]. Drugs Today (Barc), 2002, 38(11): 783-791.
  • 4颜登国,区庆嘉,李江涛.原发性肝癌生长抑素受体mRNA表达的研究[J].中华普通外科杂志,2003,18(1):55-56. 被引量:17
  • 5Komatsuzaki K, Murayama Y, Giambarella U, et al. A novel system that reports the G-proteins linked to a given receptor: a study of type 3 somatostatin receptor [J]. FEBS Lett, 1997, 406(1-2): 165-170.
  • 6Patel YC. Somatoslatin and its receptor family [ J]. Front Neuroendocrinol, 1999, 20(3): 157-198.
  • 7Patel YC, Green wood MT, Panetta R, et al. The somatostatin receptor family [J]. Life Sci, 1995, 57( 13): 1249-1265.
  • 8呼闯营,易粹琼.生长抑素受体SSTR3基因对胃癌细胞生长的影响[J].临床消化病杂志,2005,17(6):282-285. 被引量:4
  • 9Hu C, Yi C, Hao Z, et al. The effect of somatostatin and SSTR3 on proliferation and apoptosis of gastric cancer cells [ J]. Cancer Biol Ther, 2004, 3(8) : 726,:731.
  • 10Reuhi JC, Waser B, Schmassmann A, et al. Receptor autoradiographic evaluation of eholeeyestokinin, neurotension, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: where are they really located [ J] ? Int J Cancer, 1999, 81 (3) : 376-386.

二级参考文献1

共引文献19

同被引文献14

  • 1张喜梅,黄介飞,张弘,魏群,沈卫东.肝癌生长抑素受体mRNA表达的研究[J].中华肝脏病杂志,2006,14(5):383-384. 被引量:3
  • 2江兴松,张南征,王小友.胃癌组织SSTR亚型与P-ERK表达关系的研究[J].徐州医学院学报,2007,27(4):220-224. 被引量:2
  • 3KWEKKEBOOM D J, KRENNING E P. Somatostatin receptor imaging[ J]. Semin Nucl Med,2002,32(2) :84-91.
  • 4HOFLAND L J, LAMBERTS S W. Somatostatin receptor sub- type expression in human tumors [ J ]. Ann Oncol, 2001,12 ( suppl 2) :S31-36.
  • 5PATAL Y C, GREEN-WORD M T, PANETYA R, et al. Minire- view the somatostatin receptor family [ J ]. Life Sciences, 1998, 57 ( 13 ) : 1249-1265.
  • 6DENZLER B, REUBI J C. Expression of somatostatin receptors in peripheral veins of human tumors [ J ]. Cancer, 1999,85 (1) :188-198.
  • 7CARCIA- de-la-TORRE N, WASS J A, TURNER H E. Antian- giogenic effects of somatostatin analogues [ J ]. Clin Endocrinol ( Oxf), 2002,57 ( 4 ) :425-441.
  • 8SHIMON I. Somatostatin receptors in pituitary and develop- ment of somatostatin receptor subtype- selective analogs [ J ]. Endocrine,2003,20(3) :265-269.
  • 9Grimberg A. Somatostatin and cancer:applying endocrinology to oncology[J].{H}CANCER BIOLOGY & THERAPY,2004.731-733.
  • 10Joneson T,White MA,Wigler MH. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS[J].{H}SCIENCE,1996.810-812.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部